ClinicalTrials.govpublic full text
Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML
acute myeloid leukemia (aml), acute myeloid leukemia, mitoxantrone hydrochloride liposome, venetoclax, azacitidine, idarubicin, cytarabine, randomized controlled trial, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850534
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.